Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Genprex, Inc. is a clinical-stage biotechnology company developing gene therapies for cancer and diabetes. Its oncology platform uses non-viral lipid nanoparticles to deliver tumor suppressor genes, aiming to treat lung cancers and other solid tumors. The company's diabetes program focuses on gene therapies to regenerate insulin-producing cells. Its business model centers on innovative gene delivery systems, clinical trials, and strategic collaborations.
This description was generated via AI from an annual report. Updated about 1 year ago.